TVRD Tvardi Therapeutics, Inc.
Healthcare$3.44-3.64%ClosedMarket Cap: $32.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.31
P/S
0.00
EV/EBITDA
-0.48
DCF Value
$2.25
FCF Yield
-70.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-64.2%
ROA
-59.8%
ROIC
-200.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-7.1M | $-6.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-7.6M | $-7.3M | $— | — |
| FY null | $0.00 | -Infinity% | $-26.7M | $-18.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-5.9M | $-5.5M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-8.9M | $4.2M | $— | — |
| Q1 null | $2.6M | 100.0% | $-2.4M | $-4.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-10.8M | $-12.7M | $— | — |
| FY null | $7.1M | 88.6% | $-55.8M | $-70.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-5.7M | $-5.5M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-7.2M | $-7.0M | $— | — |
| Q1 null | $2.1M | 71.0% | $-29.7M | $-30.7M | $— | — |
| Q4 2023 | $3.0M | 77.0% | $-32.6M | $-32.3M | $-0.46 | — |